Skip to main content

Advertisement

SpringerLink
Log in

Nephron-sparing surgery

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

The curative management of renal cell carcinoma remains surgical. Recent advances in imaging and increased use of cross-sectional imaging modalities have led to an increased detection of incidental renal cell carcinomas. There is little debate regarding the role of nephron-sparing surgery (NSS) when absolutely indicated. Radical nephrectomy is still considered by many as the treatment of choice for localized renal cell carcinoma in the setting of a normal contralateral kidney. However, there is growing evidence that in the correct patient, the use of NSS in this setting is justified. Therefore, the indications of NSS have evolved in the past decade. Recent data indicate that radical nephrectomy and NSS provide effective and equivalent curative treatment for most renal cell carcinomas, especially those 4 cm or smaller. These data, along with new, refined surgical techniques, new studies regarding the biology of renal cell carcinoma and true incidence of occult multifocality, and earlier diagnosis make NSS an attractive consideration for the practicing urologist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Butler BP, Novick AC, Miller DP, et al.: Management of small unilateral renal cell carcinomas: radical versus nephronsparing surgery. Urology 1995, 45:34.

    Article  PubMed  CAS  Google Scholar 

  2. Lerner SE, Hawkins CA, Blute ML, et al.: Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 1996, 155:1868.

    Article  PubMed  CAS  Google Scholar 

  3. Smith SJ, Bosniak MA, Megibow AJ, et al.: Renal cell carcinoma: earlier discovery and increased detection. Radiology 1989, 170:699.

    PubMed  CAS  Google Scholar 

  4. Levine E, Huntrakoon M, Wetzel CH: Small renal neoplasms: clinical, pathologic and imaging features. Am J Roentgenol 1989, 153:69.

    CAS  Google Scholar 

  5. Dechet CB, Sebo T, Farrow G, et al.: Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J Urol 1999, 162:1282. This unique study revealed that under ideal biopsy circumstances, needle biopsy is at best 75% accurate for correct diagnosis of solid renal masses. 22% of biopsies were nondiagnostic.

    Article  PubMed  CAS  Google Scholar 

  6. Hafez KS, Novick AC, Butler B: Management of small, solitary, unilateral renal cell carcinoma: impact of central versus peripheral tumor location. J Urol 1998, 159:1156.

    Article  PubMed  CAS  Google Scholar 

  7. Bosniak MA: Observation of small incidentally detected renal masses. Semin Urol Oncol 1995, 13:267.

    PubMed  CAS  Google Scholar 

  8. Coll DM, Uzzo RG, Herts BR, et al.: 3-dimensional volume rendered computerized tomography for preoperative evaluation and intraoperative treatment of patients undergoing nephron sparing surgery. J Urol 1999, 161:1097.

    Article  PubMed  CAS  Google Scholar 

  9. Kletscher BA, Qian J, Bostwick DG, et al.: Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. J Urol 1995, 153:904–906.

    Article  PubMed  CAS  Google Scholar 

  10. Kinouchi T, Mano M, Siaki S, et al.: Incidence rate of satellite tumors in renal cell carcinoma. Cancer 1999, 86:2331–2336.

    Article  PubMed  CAS  Google Scholar 

  11. Walther MM, Lubensky IA, Venzon D, et al.: Prevalence of neoplastic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, patients with sporadic renal cell carcinoma, and no renal disease: clinical implications. J Urol 1995, 154:2010.

    Article  PubMed  CAS  Google Scholar 

  12. Ornstien DK, Lubensky IA, Venzon D, et al.: Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer. J Urol 2000, 163:431–433. Each kidney, including the normal appearing parenchyma, in patients with hereditary papillary renal cell carcinomas is estimated to harbor between 1100 and 3400 lesions with histologic features of early neoplasm.

    Article  Google Scholar 

  13. Dechet CB, Bostwick DG, Blute ML, et al.: Renal oncocytoma: multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma. J Urol 1999, 162:40–42. This is the largest series of oncocytomas specifically addressing multifocality, bilateralism, coexistence with renal cell carcinoma, and metachronous tumor development.

    Article  PubMed  CAS  Google Scholar 

  14. Steinbach F, Novick AC, Zincke H: Treatment of renal cell carcinoma in von Hippel Lindau disease: a multicenter study. J Urol 1995, 153:1812–1816.

    Article  PubMed  CAS  Google Scholar 

  15. Walther MM, Choyke PL, Glenn G, et al.: Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal surgery. J Urol 1999, 161:1475–1479.

    Article  PubMed  CAS  Google Scholar 

  16. Poston CD, Jaffe GS, Lubensky IA: Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel Lindau disease: clinical and molecular genetic implications. J Urol 1994, 153:561.

    Google Scholar 

  17. Tsui K, Shvarts O, Smith RB, et al.: Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 2000, 163:426–430.

    Article  PubMed  CAS  Google Scholar 

  18. Licht MR, Novick AC, Goormastic M: Nephron sparing surgery in incidental versus suspected renal cell carcinoma. J Urol 1994, 152:39–42.

    PubMed  CAS  Google Scholar 

  19. Fergany AF, Hafez KS, Novick AC: Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000, 163:442–445. This is a long-term study from an institution with a large experience on NSS and provides 10-year data suggesting that NSS is effective, providing long-term tumor control with preservation of renal function.

    Article  PubMed  CAS  Google Scholar 

  20. Belldegrun A, Tsui K, Dekernion JB, Smith RB: Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 Tumor-Node-Metastasis staging system. J Clin Oncol 1999, 17:2868–2875. Another long-term large study that incorporates the new 1997 TNM staging system in its analysis of the efficacy of NSS. Partial nephrectomy was found to be effective treatment for unilateral RCC less than 7 cm (ideally, < 4 cm) in the setting of a normal contralateral kidney.

    PubMed  CAS  Google Scholar 

  21. Lau W, Blute ML, Spotts B, et al.: Matched comparison of radical nephrectomy versus nephron sparing surgery for renal cancer with a normal contralateral kidney: long term followup. J Urol 2000, 163:681A. This important study is unique in that it is a matched comparison of outcome between NSS and radical nephrectomy. In the long-term, NSS is as effective as radical nephrectomy. This is the first study to show that the risk of renal failure in the long run is significantly higher in patients who undergo radical nephrectomy.

    Google Scholar 

  22. Dechet CB, Blute ML, Zincke H: Nephron-preserving surgery for unilateral renal cell carcinoma: which pathologic variables contribute to contralateral renal recurrence? J Urol 1998, 159:169A.

    Google Scholar 

  23. Novick AC, Gephardt G, Guz B, et al.: Long-term followup after partial removal of a solitary kidney. N Engl J Med 1991, 325:1058–1062.

    Article  PubMed  CAS  Google Scholar 

  24. Campbell SC, Novick AC: Surgical technique and morbidity of elective partial nephrectomy. Semin Urol Oncol 1995, 13:281–287.

    PubMed  CAS  Google Scholar 

  25. Duque JF, Loughlin KR, O’Leary MP, et al.: Partial nephrectomy: alternative treatment for selected patients with renal cell carcinoma. Urology 1998, 52:584–590.

    Article  PubMed  CAS  Google Scholar 

  26. Hafez KS, Novick AC, Campbell SC: Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma. J Urol 1997, 157:2067.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Albert Einstein College of Medicine, Montefiore Medical Center, 34 Bainbridge Avenue, 5th Floor, 10467, Bronx, NY, USA

    Reza Ghavamian MD

  2. Department of Urology, Mayo Clinic, 200 First Street S.W., 55905, Rochester, MN, USA

    Horst Zincke MD, PhD

Authors
  1. Reza Ghavamian MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Horst Zincke MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghavamian, R., Zincke, H. Nephron-sparing surgery. Curr Urol Rep 2, 34–39 (2001). https://doi.org/10.1007/s11934-001-0023-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-001-0023-y

Keywords

Search

Navigation